Gambling: Clinical Trials

5 trials for Gambling, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 5 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 35Completed 5
Phase 21Completed 1

Follow Gambling: new trials by email Literature Review of Gambling trials Research Report on Gambling

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Effect of Transcranial Direct Current Stimulation on Decision Making and Cognitive Flexibility in Gambling Disorder
Transcranial direct current stimulation - Gambling Disorder
Phase 3CompletedIstanbul University202017-03-292018-03-26
Safety and Efficacy Trial of Olanzapine in Outpatients With Pathological Gambling
olanzapine, sugar pill - Pathological Gambling
Phase 3CompletedLindner Center of HOPE422007-02-012011-12-13
Nalmefene Gambling Study: Study of Nalmefene HCl in the Treatment of Pathological Gambling
nalmefene HCl, Placebo - Pathological Gambling
Phase 2 / Phase 3CompletedSomaxon Pharmaceuticals2332005-08-012008-05-19
Minimal and Brief Treatments for Pathological Gamblers
Self-help treatment - Pathological Gambling
Phase 3CompletedUniversity of Calgary3122003-07-012009-02-16
Drug Treatment for Pathologic Gambling Disorder
Naltrexone, Placebo - Gambling
Phase 3CompletedUniversity of Chicago832002-12-012023-02-23

Narrower conditions

Disruptive, Impulse Control, and Conduct Disorders (1)

Broader conditions

Behavior (5)  ·  Mental Disorders (5)  ·  Risk-Taking (5)  ·  Disruptive, Impulse Control, and Conduct Disorders (4)

Interventions

Bibliotherapy (1)  ·  Motivational Interviewing (1)  ·  Naltrexone (1)  ·  Olanzapine (1)  ·  Sugars (1)  ·  Transcranial Direct Current Stimulation (1)  ·  nalmefene (1)

Sponsors

Istanbul University (1)  ·  Lindner Center of HOPE (1)  ·  Somaxon Pharmaceuticals (1)  ·  University of Calgary (1)  ·  University of Chicago (1)

Countries

United States (2)  ·  Canada (1)  ·  Turkey (Türkiye) (1)

Top investigators

Ahmet Z Soyata (1)  ·  David C Hodgins, PhD. (1)  ·  Philip Jochelson, MD (1)  ·  Suck Won Kim, M.D. (1)  ·  Susan L McElroy, MD (1)

Results publications

PMID 18251624, PMID 30367243

NIH funding

R21MH065920 (1)